A phase II trial of low-dose multiagent chemotherapy with gemcitabine, docetaxel, capecitabine, and cisplatin (GTX-C) in patients with metastatic pancreatic cancer.
Dung T. Le
No relevant relationships to disclose
Daniel A. Laheru
No relevant relationships to disclose
Katrina Purtell
No relevant relationships to disclose
Jennifer N. Uram
No relevant relationships to disclose
Hao Wang
No relevant relationships to disclose
Susie Lawrence
No relevant relationships to disclose
Ellen-Lilly Foreman
No relevant relationships to disclose
Jacob Joseph David
No relevant relationships to disclose
Rose Parkinson
No relevant relationships to disclose
Dionne T Savage
No relevant relationships to disclose
Ross C. Donehower
No relevant relationships to disclose
Zeshaan Rasheed
No relevant relationships to disclose
Lei Zheng
No relevant relationships to disclose
Nilofer Saba Azad
No relevant relationships to disclose
David Cosgrove
No relevant relationships to disclose
Ana De Jesus-Acosta
No relevant relationships to disclose
Ilene Browner
No relevant relationships to disclose
Luis A. Diaz
No relevant relationships to disclose